Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Advances in Health Economics and Health Services Research
|
June 25, 2009
Evaluating the value of genomic diagnostics: implications for clinical practice and public policy
Amalia M Issa
Clinical Pharmacology in Drug Development
|
January 19, 2026
From Reflection to Acceleration: Clinical Pharmacology's 2025 Lessons and 2026 Opportunities
Amalia M Issa
Clinical Pharmacology in Drug Development
|
February 6, 2026
What Makes an Early-Phase Study Worth Publishing? A View from the Editor's Desk
Amalia M Issa
Clinical Pharmacology in Drug Development
|
October 1, 2025
Model-Informed Drug Development in Early-Phase Development: Navigating Complexity With Quantitative Clarity
Amalia M Issa
Clinical Pharmacology in Drug Development
|
July 1, 2025
From Bench to Bedside and Beyond: Shaping the Future of Early-Phase Clinical Pharmacology at CPDD
Amalia M Issa
Clinical Pharmacology in Drug Development
|
April 29, 2026
The Work Behind the First Dose: How Early Clinical Studies Shape the Course of Drug Development
Amalia M Issa
Clinical Pharmacology in Drug Development
|
July 2, 2026
Beyond the "Undruggable": What Pancreatic Cancer Teaches Us About the Next Evolution of Clinical Pharmacology
Amalia M Issa
Personalized Medicine
|
May 17, 2018
Factors affecting the adoption and use of gene expression profiling by oncologists in clinical practice
Dhaval Patil, Amalia M Issa
Personalized Medicine
|
May 18, 2018
A method to measure clinical practice patterns of breast cancer genomic diagnostics in health systems
Nelson A Atehortua, Amalia M Issa
Personalized Medicine
|
May 12, 2018
The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine
Emily J Schwartz, Amalia M Issa
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Advances in Health Economics and Health Services Research
|
June 25, 2009
Evaluating the value of genomic diagnostics: implications for clinical practice and public policy
Amalia M Issa
Clinical Pharmacology in Drug Development
|
January 19, 2026
From Reflection to Acceleration: Clinical Pharmacology's 2025 Lessons and 2026 Opportunities
Amalia M Issa
Clinical Pharmacology in Drug Development
|
February 6, 2026
What Makes an Early-Phase Study Worth Publishing? A View from the Editor's Desk
Amalia M Issa
Clinical Pharmacology in Drug Development
|
October 1, 2025
Model-Informed Drug Development in Early-Phase Development: Navigating Complexity With Quantitative Clarity
Amalia M Issa
Clinical Pharmacology in Drug Development
|
July 1, 2025
From Bench to Bedside and Beyond: Shaping the Future of Early-Phase Clinical Pharmacology at CPDD
Amalia M Issa
Clinical Pharmacology in Drug Development
|
April 29, 2026
The Work Behind the First Dose: How Early Clinical Studies Shape the Course of Drug Development
Amalia M Issa
Clinical Pharmacology in Drug Development
|
July 2, 2026
Beyond the "Undruggable": What Pancreatic Cancer Teaches Us About the Next Evolution of Clinical Pharmacology
Amalia M Issa
Personalized Medicine
|
May 17, 2018
Factors affecting the adoption and use of gene expression profiling by oncologists in clinical practice
Dhaval Patil, Amalia M Issa
Personalized Medicine
|
May 18, 2018
A method to measure clinical practice patterns of breast cancer genomic diagnostics in health systems
Nelson A Atehortua, Amalia M Issa
Personalized Medicine
|
May 12, 2018
The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine
Emily J Schwartz, Amalia M Issa
Page
of 6